Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E Cigarettes

NCT07392125 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Vaping Cessation

Interventions

DRUG: Cytisinicline
DRUG: Placebo
BEHAVIORAL: Behavioral Support

Sponsor

Achieve Life Sciences